| Intrapatient tumor heterogeneity in IHC interpretation using PD-L1 IHC 22C3 pharmDx M Kalpakoff, S Hund, J Musser, C Roach, A Apostolaki, M Vilardo, L Peltz, ... Applied Immunohistochemistry & Molecular Morphology 29 (9), 667-673, 2021 | 14 | 2021 |
| Use of the Combined Positive Score (CPS) with the companion diagnostic PD-L1 IHC 22C3 pharmDx provides precise evaluation of PD-L1 expression across multiple tumor indications … F Ponce, S Hund, L Peltz, C La Placa, M Vilardo, B Watts, ... Journal for ImmunoTherapy of Cancer 9 (Suppl 2), 2021 | 3 | 2021 |
| External reproducibility of PD-L1 IHC 22C3 pharmDx for cervical cancer at CPS≥ 1 and CPS≥ 10 G Cherryholmes, A Posch, S Tabuena-Frolli, J Vasquez, T Evans, ... Journal for ImmunoTherapy of Cancer 10 (Suppl 2), 2022 | 1 | 2022 |
| PD-L1 IHC 22C3 pharmdx demonstrates precision and reproducibility in detecting PD-L1 expression in triple negative breast cancer. K Kulangara, B Watts, M Vilardo, C La Placa, J Frederick, ... Journal of Clinical Oncology 38 (15_suppl), e13104-e13104, 2020 | 1 | 2020 |
| PD-L1 IHC 22C3 pharmDx Demonstrates Precision and Reproducibility in Triple-negative Breast Cancer B Watts, M Vilardo, C La Placa, J Frederick, S Tabuena-Frolli, M Jansson, ... Journal of Cancer Treatment and Diagnosis 7 (1), 1-9, 2023 | | 2023 |
| Genetic and Hormonal Susceptibilities to SARS-CoV-2 and Severe COVID-19 CJ La Placa International Journal of Clinical Studies & Medical Case Reports, 2021 | | 2021 |
| Development of a Companion Diagnostic PD-L1 Immunohistochemistry Assay for Pembrolizumab Therapy in Head and Neck Squamous Cell Carcinoma CJ La Placa, MD Vilardo, BM Watts, MD Polewski, S Tabuena-Frolli, ... Journal of Cancer Treatment and Diagnosis 5 (1), 2021 | | 2021 |
| PD-L1 IHC 22C3 pharmDx helps determine first-line pembrolizumab eligibility in head and neck squamous cell carcinoma patients C La Placa, B Watts, M Vilardo, M Polewski, S Tabuena-Frolli, M Jansson, ... VIRCHOWS ARCHIV 477, S79-S79, 2020 | | 2020 |
| Inclusion of PD-L1-expressing tumor cells in the combined positive score algorithm yields superior identification of positive specimens around diagnostic cut-offs across … J Milo, C LaPlaca, J Hand, S Hund, A Apostolaki, L Guerrero, ... Journal for ImmunoTherapy of Cancer 8 (Suppl 3), 2020 | | 2020 |
